Medicare Part B Step Therapy Program Adds Additional Drug
By KURT WITTIG, Clinical Pharmacy Specialist
The Centers for Medicare and Medicaid Services (CMS) previously issued guidance that provides Medicare Advantage plans the option of applying step therapy for physician-administered Part B drugs in a way that lowers costs and improves the quality of care for Medicare beneficiaries.
For dates of service on or after July 1, 2020, Ziextenzo® will be added to the program.
Read more
to review the preferred alternative agents.